Nuvation Bio
Nuvation Bio is a United States-based biotechnology company running 6 late-stage cancer trials of Taletrectinib, AB-106 and NUV-1511 in non-small-cell lung cancer, HR-positive / HER2-negative breast cancer and prostate cancer.
Overview
Nuvation Bio, based in New York, NY, the United States, is a biotechnology company. A global oncology company developing therapies for difficult-to-treat cancers; its taletrectinib (IBTROZI) is FDA-approved for ROS1-positive non-small cell lung cancer. On ClinicalTrials.gov it is the lead sponsor of 6 recruiting or active phase 2 and phase 3 interventional cancer trials (3 in phase 3), testing Taletrectinib, AB-106, NUV-1511 and safusidenib in non-small-cell lung cancer, HR-positive / HER2-negative breast cancer, prostate cancer, pancreatic ductal adenocarcinoma and ovarian cancer. The largest, NCT06334432 (Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumours), plans to enrol 466 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 3 +3
- targets +2
- modalities +2
Similar pages
not linked directly; found by shared links- CompanyShenzhen Ionova Life Sciences
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer, HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Pancreatic ductal adenocarcinoma, Prostate cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCivaTech Oncology
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyInxMed (Shanghai)
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyEvopoint Biosciences
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag ctgov-sponsor.
- CompanyOncolytics Biotech
Shares Pancreatic ductal adenocarcinoma, HR-positive / HER2-negative breast cancer and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.